The Neuromodulation Devices And Implantable Infusion Pumps market revenue was xx.xx Million USD in 2019, and will reach xx.xx Million USD in 2025, with a CAGR of x.x% during 2020-2025.
Under COVID-19 outbreak globally, this report provides 360 degrees of analysis from supply chain, import and export control to regional government policy and future influence on the industry. Detailed analysis about market status (2015-2020), enterprise competition pattern, advantages and disadvantages of enterprise products, industry development trends (2020-2025), regional industrial layout characteristics and macroeconomic policies, industrial policy has also been included. From raw materials to end users of this industry are analyzed scientifically, the trends of product circulation and sales channel will be presented as well. Considering COVID-19, this report provides comprehensive and in-depth analysis on how the epidemic push this industry transformation and reform.
In COVID-19 outbreak, Chapter 2.2 of this report provides an analysis of the impact of COVID-19 on the global economy and the Neuromodulation Devices And Implantable Infusion Pumps industry.
Chapter 3.7 covers the analysis of the impact of COVID-19 from the perspective of the industry chain.
In addition, chapters 7-11 consider the impact of COVID-19 on the regional economy.
The Neuromodulation Devices And Implantable Infusion Pumps market can be split based on product types, major applications, and important countries as follows:
Key players in the global Neuromodulation Devices And Implantable Infusion Pumps market covered in Chapter 12:
Medtronic
Cyberonics
Neuropace
Boston Scientific Corporation
Greatbatch Medical
Synapse Biomedical
Nevro Corporation
St. Jude Medical
Avery Biomedical
Autonomic Technologies
In Chapter 4 and 14.1, on the basis of types, the Neuromodulation Devices And Implantable Infusion Pumps market from 2015 to 2025 is primarily split into:
Vagal Nerve Stimulation
Sacral Nerve Stimulation
Deep Brain Stimulation
Spinal Cord Stimulation
In Chapter 5 and 14.2, on the basis of applications, the Neuromodulation Devices And Implantable Infusion Pumps market from 2015 to 2025 covers:
Pain
Epilepsy
Parkinson's disease
Others
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2025) of the following regions are covered in Chapter 6, 7, 8, 9, 10, 11, 14:
North America (Covered in Chapter 7 and 14)
United States
Canada
Mexico
Europe (Covered in Chapter 8 and 14)
Germany
UK
France
Italy
Spain
Russia
Others
Asia-Pacific (Covered in Chapter 9 and 14)
China
Japan
South Korea
Australia
India
Southeast Asia
Others
Middle East and Africa (Covered in Chapter 10 and 14)
Saudi Arabia
UAE
Egypt
Nigeria
South Africa
Others
South America (Covered in Chapter 11 and 14)
Brazil
Argentina
Columbia
Chile
Others
Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2025
Table of Content
1 Neuromodulation Devices And Implantable Infusion Pumps Introduction and Market Overview
1.1 Objectives of the Study
1.2 Overview of Neuromodulation Devices And Implantable Infusion Pumps
1.3 Scope of The Study
1.3.1 Key Market Segments
1.3.2 Players Covered
1.3.3 COVID-19's impact on the Neuromodulation Devices And Implantable Infusion Pumps industry
1.4 Methodology of The Study
1.5 Research Data Source
2 Executive Summary
2.1 Market Overview
2.1.1 Global Neuromodulation Devices And Implantable Infusion Pumps Market Size, 2015 - 2020
2.1.2 Global Neuromodulation Devices And Implantable Infusion Pumps Market Size by Type, 2015 - 2020
2.1.3 Global Neuromodulation Devices And Implantable Infusion Pumps Market Size by Application, 2015 - 2020
2.1.4 Global Neuromodulation Devices And Implantable Infusion Pumps Market Size by Region, 2015 - 2025
2.2 Business Environment Analysis
2.2.1 Global COVID-19 Status and Economic Overview
2.2.2 Influence of COVID-19 Outbreak on Neuromodulation Devices And Implantable Infusion Pumps Industry Development
3 Industry Chain Analysis
3.1 Upstream Raw Material Suppliers of Neuromodulation Devices And Implantable Infusion Pumps Analysis
3.2 Major Players of Neuromodulation Devices And Implantable Infusion Pumps
3.3 Neuromodulation Devices And Implantable Infusion Pumps Manufacturing Cost Structure Analysis
3.3.1 Production Process Analysis
3.3.2 Manufacturing Cost Structure of Neuromodulation Devices And Implantable Infusion Pumps
3.3.3 Labor Cost of Neuromodulation Devices And Implantable Infusion Pumps
3.4 Market Distributors of Neuromodulation Devices And Implantable Infusion Pumps
3.5 Major Downstream Buyers of Neuromodulation Devices And Implantable Infusion Pumps Analysis
3.6 The Impact of Covid-19 From the Perspective of Industry Chain
3.7 Regional Import and Export Controls Will Exist for a Long Time
3.8 Continued downward PMI Spreads Globally
4 Global Neuromodulation Devices And Implantable Infusion Pumps Market, by Type
4.1 Global Neuromodulation Devices And Implantable Infusion Pumps Value and Market Share by Type (2015-2020)
4.2 Global Neuromodulation Devices And Implantable Infusion Pumps Production and Market Share by Type (2015-2020)
4.3 Global Neuromodulation Devices And Implantable Infusion Pumps Value and Growth Rate by Type (2015-2020)
4.3.1 Global Neuromodulation Devices And Implantable Infusion Pumps Value and Growth Rate of Vagal Nerve Stimulation
4.3.2 Global Neuromodulation Devices And Implantable Infusion Pumps Value and Growth Rate of Sacral Nerve Stimulation
4.3.3 Global Neuromodulation Devices And Implantable Infusion Pumps Value and Growth Rate of Deep Brain Stimulation
4.3.4 Global Neuromodulation Devices And Implantable Infusion Pumps Value and Growth Rate of Spinal Cord Stimulation
4.4 Global Neuromodulation Devices And Implantable Infusion Pumps Price Analysis by Type (2015-2020)
5 Neuromodulation Devices And Implantable Infusion Pumps Market, by Application
5.1 Downstream Market Overview
5.2 Global Neuromodulation Devices And Implantable Infusion Pumps Consumption and Market Share by Application (2015-2020)
5.3 Global Neuromodulation Devices And Implantable Infusion Pumps Consumption and Growth Rate by Application (2015-2020)
5.3.1 Global Neuromodulation Devices And Implantable Infusion Pumps Consumption and Growth Rate of Pain (2015-2020)
5.3.2 Global Neuromodulation Devices And Implantable Infusion Pumps Consumption and Growth Rate of Epilepsy (2015-2020)
5.3.3 Global Neuromodulation Devices And Implantable Infusion Pumps Consumption and Growth Rate of Parkinson's disease (2015-2020)
5.3.4 Global Neuromodulation Devices And Implantable Infusion Pumps Consumption and Growth Rate of Others (2015-2020)
6 Global Neuromodulation Devices And Implantable Infusion Pumps Market Analysis by Regions
6.1 Global Neuromodulation Devices And Implantable Infusion Pumps Sales, Revenue and Market Share by Regions
6.1.1 Global Neuromodulation Devices And Implantable Infusion Pumps Sales by Regions (2015-2020)
6.1.2 Global Neuromodulation Devices And Implantable Infusion Pumps Revenue by Regions (2015-2020)
6.2 North America Neuromodulation Devices And Implantable Infusion Pumps Sales and Growth Rate (2015-2020)
6.3 Europe Neuromodulation Devices And Implantable Infusion Pumps Sales and Growth Rate (2015-2020)
6.4 Asia-Pacific Neuromodulation Devices And Implantable Infusion Pumps Sales and Growth Rate (2015-2020)
6.5 Middle East and Africa Neuromodulation Devices And Implantable Infusion Pumps Sales and Growth Rate (2015-2020)
6.6 South America Neuromodulation Devices And Implantable Infusion Pumps Sales and Growth Rate (2015-2020)
7 North America Neuromodulation Devices And Implantable Infusion Pumps Market Analysis by Countries
7.1 The Influence of COVID-19 on North America Market
7.2 North America Neuromodulation Devices And Implantable Infusion Pumps Sales, Revenue and Market Share by Countries
7.2.1 North America Neuromodulation Devices And Implantable Infusion Pumps Sales by Countries (2015-2020)
7.2.2 North America Neuromodulation Devices And Implantable Infusion Pumps Revenue by Countries (2015-2020)
7.3 United States Neuromodulation Devices And Implantable Infusion Pumps Sales and Growth Rate (2015-2020)
7.4 Canada Neuromodulation Devices And Implantable Infusion Pumps Sales and Growth Rate (2015-2020)
7.5 Mexico Neuromodulation Devices And Implantable Infusion Pumps Sales and Growth Rate (2015-2020)
8 Europe Neuromodulation Devices And Implantable Infusion Pumps Market Analysis by Countries
8.1 The Influence of COVID-19 on Europe Market
8.2 Europe Neuromodulation Devices And Implantable Infusion Pumps Sales, Revenue and Market Share by Countries
8.2.1 Europe Neuromodulation Devices And Implantable Infusion Pumps Sales by Countries (2015-2020)
8.2.2 Europe Neuromodulation Devices And Implantable Infusion Pumps Revenue by Countries (2015-2020)
8.3 Germany Neuromodulation Devices And Implantable Infusion Pumps Sales and Growth Rate (2015-2020)
8.4 UK Neuromodulation Devices And Implantable Infusion Pumps Sales and Growth Rate (2015-2020)
8.5 France Neuromodulation Devices And Implantable Infusion Pumps Sales and Growth Rate (2015-2020)
8.6 Italy Neuromodulation Devices And Implantable Infusion Pumps Sales and Growth Rate (2015-2020)
8.7 Spain Neuromodulation Devices And Implantable Infusion Pumps Sales and Growth Rate (2015-2020)
8.8 Russia Neuromodulation Devices And Implantable Infusion Pumps Sales and Growth Rate (2015-2020)
9 Asia Pacific Neuromodulation Devices And Implantable Infusion Pumps Market Analysis by Countries
9.1 The Influence of COVID-19 on Asia Pacific Market
9.2 Asia Pacific Neuromodulation Devices And Implantable Infusion Pumps Sales, Revenue and Market Share by Countries
9.2.1 Asia Pacific Neuromodulation Devices And Implantable Infusion Pumps Sales by Countries (2015-2020)
9.2.2 Asia Pacific Neuromodulation Devices And Implantable Infusion Pumps Revenue by Countries (2015-2020)
9.3 China Neuromodulation Devices And Implantable Infusion Pumps Sales and Growth Rate (2015-2020)
9.4 Japan Neuromodulation Devices And Implantable Infusion Pumps Sales and Growth Rate (2015-2020)
9.5 South Korea Neuromodulation Devices And Implantable Infusion Pumps Sales and Growth Rate (2015-2020)
9.6 India Neuromodulation Devices And Implantable Infusion Pumps Sales and Growth Rate (2015-2020)
9.7 Southeast Asia Neuromodulation Devices And Implantable Infusion Pumps Sales and Growth Rate (2015-2020)
9.8 Australia Neuromodulation Devices And Implantable Infusion Pumps Sales and Growth Rate (2015-2020)
10 Middle East and Africa Neuromodulation Devices And Implantable Infusion Pumps Market Analysis by Countries
10.1 The Influence of COVID-19 on Middle East and Africa Market
10.2 Middle East and Africa Neuromodulation Devices And Implantable Infusion Pumps Sales, Revenue and Market Share by Countries
10.2.1 Middle East and Africa Neuromodulation Devices And Implantable Infusion Pumps Sales by Countries (2015-2020)
10.2.2 Middle East and Africa Neuromodulation Devices And Implantable Infusion Pumps Revenue by Countries (2015-2020)
10.3 Saudi Arabia Neuromodulation Devices And Implantable Infusion Pumps Sales and Growth Rate (2015-2020)
10.4 UAE Neuromodulation Devices And Implantable Infusion Pumps Sales and Growth Rate (2015-2020)
10.5 Egypt Neuromodulation Devices And Implantable Infusion Pumps Sales and Growth Rate (2015-2020)
10.6 Nigeria Neuromodulation Devices And Implantable Infusion Pumps Sales and Growth Rate (2015-2020)
10.7 South Africa Neuromodulation Devices And Implantable Infusion Pumps Sales and Growth Rate (2015-2020)
11 South America Neuromodulation Devices And Implantable Infusion Pumps Market Analysis by Countries
11.1 The Influence of COVID-19 on Middle East and Africa Market
11.2 South America Neuromodulation Devices And Implantable Infusion Pumps Sales, Revenue and Market Share by Countries
11.2.1 South America Neuromodulation Devices And Implantable Infusion Pumps Sales by Countries (2015-2020)
11.2.2 South America Neuromodulation Devices And Implantable Infusion Pumps Revenue by Countries (2015-2020)
11.3 Brazil Neuromodulation Devices And Implantable Infusion Pumps Sales and Growth Rate (2015-2020)
11.4 Argentina Neuromodulation Devices And Implantable Infusion Pumps Sales and Growth Rate (2015-2020)
11.5 Columbia Neuromodulation Devices And Implantable Infusion Pumps Sales and Growth Rate (2015-2020)
11.6 Chile Neuromodulation Devices And Implantable Infusion Pumps Sales and Growth Rate (2015-2020)
12 Competitive Landscape
12.1 Medtronic
12.1.1 Medtronic Basic Information
12.1.2 Neuromodulation Devices And Implantable Infusion Pumps Product Introduction
12.1.3 Medtronic Production, Value, Price, Gross Margin 2015-2020
12.2 Cyberonics
12.2.1 Cyberonics Basic Information
12.2.2 Neuromodulation Devices And Implantable Infusion Pumps Product Introduction
12.2.3 Cyberonics Production, Value, Price, Gross Margin 2015-2020
12.3 Neuropace
12.3.1 Neuropace Basic Information
12.3.2 Neuromodulation Devices And Implantable Infusion Pumps Product Introduction
12.3.3 Neuropace Production, Value, Price, Gross Margin 2015-2020
12.4 Boston Scientific Corporation
12.4.1 Boston Scientific Corporation Basic Information
12.4.2 Neuromodulation Devices And Implantable Infusion Pumps Product Introduction
12.4.3 Boston Scientific Corporation Production, Value, Price, Gross Margin 2015-2020
12.5 Greatbatch Medical
12.5.1 Greatbatch Medical Basic Information
12.5.2 Neuromodulation Devices And Implantable Infusion Pumps Product Introduction
12.5.3 Greatbatch Medical Production, Value, Price, Gross Margin 2015-2020
12.6 Synapse Biomedical
12.6.1 Synapse Biomedical Basic Information
12.6.2 Neuromodulation Devices And Implantable Infusion Pumps Product Introduction
12.6.3 Synapse Biomedical Production, Value, Price, Gross Margin 2015-2020
12.7 Nevro Corporation
12.7.1 Nevro Corporation Basic Information
12.7.2 Neuromodulation Devices And Implantable Infusion Pumps Product Introduction
12.7.3 Nevro Corporation Production, Value, Price, Gross Margin 2015-2020
12.8 St. Jude Medical
12.8.1 St. Jude Medical Basic Information
12.8.2 Neuromodulation Devices And Implantable Infusion Pumps Product Introduction
12.8.3 St. Jude Medical Production, Value, Price, Gross Margin 2015-2020
12.9 Avery Biomedical
12.9.1 Avery Biomedical Basic Information
12.9.2 Neuromodulation Devices And Implantable Infusion Pumps Product Introduction
12.9.3 Avery Biomedical Production, Value, Price, Gross Margin 2015-2020
12.10 Autonomic Technologies
12.10.1 Autonomic Technologies Basic Information
12.10.2 Neuromodulation Devices And Implantable Infusion Pumps Product Introduction
12.10.3 Autonomic Technologies Production, Value, Price, Gross Margin 2015-2020
13 Industry Outlook
13.1 Market Driver Analysis
13.1.2 Market Restraints Analysis
13.1.3 Market Trends Analysis
13.2 Merger, Acquisition and New Investment
13.3 News of Product Release
14 Global Neuromodulation Devices And Implantable Infusion Pumps Market Forecast
14.1 Global Neuromodulation Devices And Implantable Infusion Pumps Market Value & Volume Forecast, by Type (2020-2025)
14.1.1 Vagal Nerve Stimulation Market Value and Volume Forecast (2020-2025)
14.1.2 Sacral Nerve Stimulation Market Value and Volume Forecast (2020-2025)
14.1.3 Deep Brain Stimulation Market Value and Volume Forecast (2020-2025)
14.1.4 Spinal Cord Stimulation Market Value and Volume Forecast (2020-2025)
14.2 Global Neuromodulation Devices And Implantable Infusion Pumps Market Value & Volume Forecast, by Application (2020-2025)
14.2.1 Pain Market Value and Volume Forecast (2020-2025)
14.2.2 Epilepsy Market Value and Volume Forecast (2020-2025)
14.2.3 Parkinson's disease Market Value and Volume Forecast (2020-2025)
14.2.4 Others Market Value and Volume Forecast (2020-2025)
14.3 Neuromodulation Devices And Implantable Infusion Pumps Market Analysis and Forecast by Region
14.3.1 North America Market Value and Consumption Forecast (2020-2025)
14.3.2 Europe Market Value and Consumption Forecast (2020-2025)
14.3.3 Asia Pacific Market Value and Consumption Forecast (2020-2025)
14.3.4 Middle East and Africa Market Value and Consumption Forecast (2020-2025)
14.3.5 South America Market Value and Consumption Forecast (2020-2025)
15 New Project Feasibility Analysis
15.1 Industry Barriers and New Entrants SWOT Analysis
15.1.1 Porter